Pilocarpine
Glaucoma · Rx
RxGlaucomaGlaucoma Chol Dark green cap
| Strength | 1%, 2%, 4% (glaucoma); 1.25% (Vuity, presbyopia) |
|---|---|
| Typical quantity | 15 mL (Isopto Carpine, cheap generic) or 1.7 mL x30 vials (Vuity, presbyopia) |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Cholinergic (muscarinic) agonist / miotic |
| Mechanism of action | Direct muscarinic agonist; contracts the ciliary muscle to open the trabecular meshwork (increases outflow) and contracts the iris sphincter (miosis, pulls peripheral iris away from the angle). |
| Indication / reason for use | Acute and chronic angle-closure (breaks pupillary block once the iris is not ischemic), before/after laser peripheral iridotomy, plateau iris, pilocarpine test for Adie pupil; Vuity 1.25% for presbyopia (pinhole effect). |
| Usual adult dosing | Angle-closure: 1-2% one drop, may repeat once after 15 min then reassess. Chronic: QID. Vuity: 1 drop each eye once daily. |
| Preservative | BAK |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | Brow ache / accommodative spasm (marked in young patients), dim vision especially at night (miosis), induced myopia, retinal detachment risk (traction on the peripheral retina, examine high-risk eyes first), increased risk of posterior synechiae in uveitis, rarely precipitates angle-closure by anterior lens movement. |
| Contraindications & cautions | Uveitic and neovascular glaucoma, most secondary angle-closure not due to pupillary block, malignant glaucoma, peripheral retinal pathology / high myopia (relative), pupillary-block angle-closure with an ischemic (fixed) iris, pilocarpine won't work until IOP is lowered medically. |
| Pregnancy / lactation | Limited data; use only if clearly needed. |
| Trade names | Isopto Carpine, Vuity (1.25%, presbyopia) |
| Practice notes | In an acute angle-closure attack, the sphincter is often ischemic and unresponsive until IOP is brought down with systemic agents, don't rely on pilocarpine alone. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.